vs

Side-by-side financial comparison of Cadre Holdings, Inc. (CDRE) and PROASSURANCE CORP (PRA). Click either name above to swap in a different company.

PROASSURANCE CORP is the larger business by last-quarter revenue ($269.6M vs $167.2M, roughly 1.6× Cadre Holdings, Inc.). PROASSURANCE CORP runs the higher net margin — 12.4% vs 7.0%, a 5.4% gap on every dollar of revenue. On growth, Cadre Holdings, Inc. posted the faster year-over-year revenue change (-5.0% vs -7.1%). Over the past eight quarters, Cadre Holdings, Inc.'s revenue compounded faster (10.1% CAGR vs -2.7%).

RealCadre LLC, commonly Cadre, is an American financial technology company that provides individuals and institutions direct access to real estate investment properties, including commercial properties based in New York. The business and financial press describe it as a platform that "makes the real estate market more like the stock market" by allowing investors to select the individual transactions in which they participate, while investing a smaller amount than would be required to fully fu...

ProAssurance Corporation, headquartered in Birmingham, Alabama, is a property and casualty company that sells professional liability insurance to doctors. The company was founded in 1976 as Mutual Assurance and was later renamed to Medical Assurance in 1997. The name "ProAssurance" was created in 2001 when Medical Assurance merged with Professionals Group. The company is currently the fourth largest medical professional liability insurance writer and has over $6 billion in assets.

CDRE vs PRA — Head-to-Head

Bigger by revenue
PRA
PRA
1.6× larger
PRA
$269.6M
$167.2M
CDRE
Growing faster (revenue YoY)
CDRE
CDRE
+2.1% gap
CDRE
-5.0%
-7.1%
PRA
Higher net margin
PRA
PRA
5.4% more per $
PRA
12.4%
7.0%
CDRE
Faster 2-yr revenue CAGR
CDRE
CDRE
Annualised
CDRE
10.1%
-2.7%
PRA

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CDRE
CDRE
PRA
PRA
Revenue
$167.2M
$269.6M
Net Profit
$11.7M
$33.4M
Gross Margin
43.4%
Operating Margin
12.2%
17.3%
Net Margin
7.0%
12.4%
Revenue YoY
-5.0%
-7.1%
Net Profit YoY
-9.6%
106.4%
EPS (diluted)
$0.22
$0.65

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CDRE
CDRE
PRA
PRA
Q4 25
$167.2M
$269.6M
Q3 25
$155.9M
$279.6M
Q2 25
$157.1M
$276.8M
Q1 25
$130.1M
$272.1M
Q4 24
$176.0M
$290.1M
Q3 24
$109.4M
$285.3M
Q2 24
$144.3M
$290.4M
Q1 24
$137.9M
$284.7M
Net Profit
CDRE
CDRE
PRA
PRA
Q4 25
$11.7M
$33.4M
Q3 25
$10.9M
$1.4M
Q2 25
$12.2M
$21.9M
Q1 25
$9.2M
$-5.8M
Q4 24
$13.0M
$16.2M
Q3 24
$3.7M
$16.4M
Q2 24
$12.6M
$15.5M
Q1 24
$6.9M
$4.6M
Gross Margin
CDRE
CDRE
PRA
PRA
Q4 25
43.4%
Q3 25
42.7%
Q2 25
40.9%
Q1 25
43.1%
Q4 24
43.9%
Q3 24
36.6%
Q2 24
40.6%
Q1 24
41.8%
Operating Margin
CDRE
CDRE
PRA
PRA
Q4 25
12.2%
17.3%
Q3 25
12.0%
1.6%
Q2 25
9.3%
9.9%
Q1 25
10.4%
-2.3%
Q4 24
16.7%
6.5%
Q3 24
5.0%
7.4%
Q2 24
13.8%
6.2%
Q1 24
8.7%
1.9%
Net Margin
CDRE
CDRE
PRA
PRA
Q4 25
7.0%
12.4%
Q3 25
7.0%
0.5%
Q2 25
7.8%
7.9%
Q1 25
7.1%
-2.1%
Q4 24
7.4%
5.6%
Q3 24
3.3%
5.8%
Q2 24
8.7%
5.3%
Q1 24
5.0%
1.6%
EPS (diluted)
CDRE
CDRE
PRA
PRA
Q4 25
$0.22
$0.65
Q3 25
$0.27
$0.03
Q2 25
$0.30
$0.42
Q1 25
$0.23
$-0.11
Q4 24
$0.32
$0.32
Q3 24
$0.09
$0.32
Q2 24
$0.31
$0.30
Q1 24
$0.18
$0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CDRE
CDRE
PRA
PRA
Cash + ST InvestmentsLiquidity on hand
$122.9M
$36.5M
Total DebtLower is stronger
$420.4M
Stockholders' EquityBook value
$317.8M
$1.3B
Total Assets
$770.0M
$5.4B
Debt / EquityLower = less leverage
0.31×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CDRE
CDRE
PRA
PRA
Q4 25
$122.9M
$36.5M
Q3 25
$150.9M
$54.5M
Q2 25
$137.5M
$41.6M
Q1 25
$133.4M
$43.5M
Q4 24
$124.9M
$54.9M
Q3 24
$93.0M
$45.3M
Q2 24
$105.9M
$36.9M
Q1 24
$87.1M
$65.4M
Total Debt
CDRE
CDRE
PRA
PRA
Q4 25
$420.4M
Q3 25
$421.5M
Q2 25
$422.6M
Q1 25
$423.7M
Q4 24
$424.9M
Q3 24
$425.9M
Q2 24
$426.9M
Q1 24
$427.8M
Stockholders' Equity
CDRE
CDRE
PRA
PRA
Q4 25
$317.8M
$1.3B
Q3 25
$340.4M
$1.3B
Q2 25
$332.5M
$1.3B
Q1 25
$317.6M
$1.2B
Q4 24
$311.5M
$1.2B
Q3 24
$300.3M
$1.2B
Q2 24
$299.4M
$1.1B
Q1 24
$270.7M
$1.1B
Total Assets
CDRE
CDRE
PRA
PRA
Q4 25
$770.0M
$5.4B
Q3 25
$792.1M
$5.6B
Q2 25
$794.4M
$5.5B
Q1 25
$656.3M
$5.5B
Q4 24
$652.7M
$5.6B
Q3 24
$616.6M
$5.7B
Q2 24
$620.6M
$5.6B
Q1 24
$599.4M
$5.7B
Debt / Equity
CDRE
CDRE
PRA
PRA
Q4 25
0.31×
Q3 25
0.32×
Q2 25
0.33×
Q1 25
0.34×
Q4 24
0.35×
Q3 24
0.35×
Q2 24
0.38×
Q1 24
0.38×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CDRE
CDRE
PRA
PRA
Operating Cash FlowLast quarter
$21.3M
$-25.6M
Free Cash FlowOCF − Capex
$18.0M
FCF MarginFCF / Revenue
10.7%
Capex IntensityCapex / Revenue
2.0%
Cash ConversionOCF / Net Profit
1.81×
-0.77×
TTM Free Cash FlowTrailing 4 quarters
$56.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CDRE
CDRE
PRA
PRA
Q4 25
$21.3M
$-25.6M
Q3 25
$22.5M
$27.2M
Q2 25
$2.6M
$-28.1M
Q1 25
$17.4M
$-11.6M
Q4 24
$23.7M
$-10.7M
Q3 24
$-5.2M
$14.0M
Q2 24
$11.1M
$-12.8M
Q1 24
$2.1M
$-11.6M
Free Cash Flow
CDRE
CDRE
PRA
PRA
Q4 25
$18.0M
Q3 25
$21.6M
Q2 25
$1.2M
Q1 25
$16.1M
Q4 24
$22.4M
Q3 24
$-6.2M
Q2 24
$9.1M
Q1 24
$794.0K
FCF Margin
CDRE
CDRE
PRA
PRA
Q4 25
10.7%
Q3 25
13.9%
Q2 25
0.7%
Q1 25
12.4%
Q4 24
12.7%
Q3 24
-5.7%
Q2 24
6.3%
Q1 24
0.6%
Capex Intensity
CDRE
CDRE
PRA
PRA
Q4 25
2.0%
Q3 25
0.5%
Q2 25
0.9%
Q1 25
1.0%
Q4 24
0.7%
Q3 24
0.9%
Q2 24
1.4%
Q1 24
1.0%
Cash Conversion
CDRE
CDRE
PRA
PRA
Q4 25
1.81×
-0.77×
Q3 25
2.05×
18.81×
Q2 25
0.21×
-1.28×
Q1 25
1.88×
Q4 24
1.83×
-0.66×
Q3 24
-1.43×
0.85×
Q2 24
0.89×
-0.83×
Q1 24
0.31×
-2.52×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CDRE
CDRE

U.s.state And Local Agencies$72.7M43%
Other$48.6M29%
U.s.Federal Agencies$31.6M19%
Commercial$12.0M7%

PRA
PRA

Workers Compensation Insurance Segment$164.4M61%
Other$59.6M22%
Segregated Portfolio Cell Reinsurance$45.7M17%

Related Comparisons